Proton Therapy Market By Indication (Head and Neck Cancer, CNS Cancer, Prostate Cancer, Breast Cancer, Others), By Product Type (Accelerator, Beam Transport System, Beam Delivery System, Nozzle and Image Viewers, Patient Positioning System), By End User (Hospitals, Proton Therapy Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global proton therapy market was valued at $438.33 million in 2021, and is projected to reach $1579.39 million by 2031, registering a CAGR of 13.65% from 2022 to 2031.
Proton therapy is the most precise and advanced type of radiation therapy. It is widely used to treat cancer. It has a number of advantages over traditional radiation therapy, in terms of efficacy and adverse effects. It is a pleasant, non-invasive treatment that helps patients retain their quality of life and return to normal activities fast. It enables doctors to administer full or greater treatment dosages that kill primary tumors without harming healthy tissues or organs. Major limitations of photon therapy or other particle therapies are overcome by proton therapy. Advancements in technology have increased adoption of proton therapy for treatments of various cancers across the globe.
Demand for proton therapy is anticipated to increase globally during the forecast period, owing to increase in prevalence of cancer and surge in number of awareness campaigns about benefits of proton therapy and technological advancements in radiotherapy devices. Moreover, patients are eager to know more about proton therapy treatment process and increase in recognition of proton therapy drive growth of the market, globally. However, higher cost of proton therapy is anticipated to hamper the market growth. In addition, proton therapy devices are very large in size and require large space with dedicated areas. The setup cost is exclusive of the device cost, which further increases investments, thereby restraining growth of this market. Moreover, introduction of proton therapy in emerging economies is expected to offer lucrative growth opportunities for key players in the market.
The global proton therapy market is segmented into indications, product type, end user, and region. By indication, the market is divided into head & neck cancer, central nervous system cancer, prostate cancer, breast cancer, and others. According to product type, it is bifurcated into accelerator, beam transport system, beam delivery system, nozzles & image viewers, and patient positioning system. On the basis of end user market, it is divided into hospitals, proton therapy centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Major companies profiled in the report include Hitachi, Ltd., Ion Beam Applications S.A., Mevion Medical Systems, Mirion Technologies Ltd., Optivus Proton Therapy, Inc., Provision Healthcare, Pro Tom International, Siemens, Sumitomo Heavy Industries, Ltd., and Toshiba Corporation.
KEY BENEFITS FOR STAKEHOLDERS
This report provides an in-depth analysis of the proton therapy market with current trends and estimations from 2022 to 2031.
Geographical analysis of the market is expected to help companies to plan their strategies accordingly and take region specific decisions.
Analysis of key strategies adopted by market players is expected to provide market intelligence and help stakeholders understand competitive structure of the market.
The report analyzes market conditions in a comprehensive and quantitative manner and forecasts market trends and techniques for proton therapy applications.
Key Market Segments
By Indication
Head and Neck Cancer
CNS Cancer
Prostate Cancer
Breast Cancer
Others
By Product Type
Accelerator
Beam Transport System
Beam Delivery System
Nozzle and Image Viewers
Patient Positioning System
By End User
Hospitals
Proton Therapy Centers
Others
By Region
North America
U.S.
Europe
Germany
France
U.K.
Rest of Europe
Asia-Pacific
Japan
China
South Korea
Rest of Asia-Pacific
LAMEA
Saudi Arabia
Key Market Players
ION BEAM APPLICATIONS
Provision Healthcare
HITACHI LTD.
MEVION MEDICAL SYSTEMS
OPTIVUS PROTON THERAPY INC.
PRONOVA SOLUTIONS LLC.
SUMITOMO CORPORATION
Siemens Ltd
Mirion Technologies
Toshiba Corp.
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook